Evidence map›Paper›PMID 35744674›Full record

ArticleMicroorganisms2022

Comparative Evaluation of Antimicrobial, Antiamoebic, and Antiviral Efficacy of Ophthalmic Formulations.

Ciro Caruso, Daniela Eletto, Alessandra Tosco, Martina Pannetta, Fabio Scarinci, Mario Troisi, Amalia Porta

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.1field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Ciro CarusoCorneal Transplant Centre, Pellegrini Hospital, 80134 Naples, Italy.ORCID 0000-0002-6023-4277
Daniela ElettoDepartment of Pharmacy, University of Salerno, 84084 Fisciano, Italy.ORCID 0000-0001-6967-1812
Alessandra ToscoDepartment of Pharmacy, University of Salerno, 84084 Fisciano, Italy.ORCID 0000-0002-5443-1565
Martina PannettaDepartment of Pharmacy, University of Salerno, 84084 Fisciano, Italy.
Fabio ScarinciDepartment of Ophthalmology, IRCCS Fondazione, Bietti, Via Livenza, 3, 00198 Roma, Italy.ORCID 0000-0001-5444-4377
Mario TroisiDepartment of Neurosciences, Reproductive Sciences and Dentistry, Eye Clinic, University of Naples "Federico II", 80138 Naples, Italy.ORCID 0000-0003-3492-014X
Amalia PortaDepartment of Pharmacy, University of Salerno, 84084 Fisciano, Italy.ORCID 0000-0001-5947-9472
University of Salerno · ITFondazione G.B. Bietti · ITOspedale dei Pellegrini · ITUniversity of Naples Federico II · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The extensive use of ophthalmic antibiotics is contributing to the appearance of resistant bacterial strains, which require prolonged and massive treatments with consequent detrimental outcomes and adverse effects. In addition to these issues, antibiotics are not effective against parasites and viruses. In this context, antiseptics could be valuable alternatives. They have nonselective mechanisms of action preventing bacterial resistance and a broad spectrum of action and are also effective against parasites and viruses. Here, we compare the in vitro antibacterial, antiameobic, and antiviral activities of six ophthalmic formulations containing antiseptics such as povidone-iodine, chlorhexidine, and thymol against Gram-positive and Gram-negative bacteria, the amoeba

Indexed as

antiamoebicantibacterialantisepticsantiviralchlorhexidineeye dropsophthalmic solutionthymol

Identifiers

PMID35744674
PMCPMC9229167
OpenAlexW4281654408

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.